These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 6166877)

  • 21. Antifibrillatory action of the stable orally active prostacyclin analogues iloprost and ZK 96 480 in rats after coronary artery ligation.
    Müller B; Maass B; Stürzebecher S; Skuballa W
    Biomed Biochim Acta; 1984; 43(8-9):S175-8. PubMed ID: 6083785
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of PGI2 and CH-5084 on the arterial smooth muscle tone, blood pressure and platelet aggregation.
    Hadházy P; Malomvölgyi B; Hermán F; Magyar K; Kovács G
    Prog Clin Biol Res; 1987; 242():113-7. PubMed ID: 3313408
    [No Abstract]   [Full Text] [Related]  

  • 23. Control of human and animal platelet aggregation by a new prostacyclin analog.
    Maderna P; Colli S; Sirtori C; Tremoli E; Paoletti R
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():363-9. PubMed ID: 2408447
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Critical evaluation of the in vivo selectivity between hypotensive and platelet antiaggregating actions of iloprost and prostacyclin in beagle dogs.
    Hermán F; Hadházy P; Magyar K
    Arch Int Pharmacodyn Ther; 1989; 300():281-91. PubMed ID: 2482710
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of iloprost (ZK 36374), a prostacyclin derivative, on platelet function after ischaemic exercise in patients with stable angina pectoris.
    Grauso F; Biagi G; Puddu P; Bugiardini R; Capelli M; Coccheri S
    Thromb Res; 1987 Oct; 48(2):131-43. PubMed ID: 2447664
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human plasma transforms prostacyclin (PGI2) into a platelet antiaggregatory substance which contracts isolated bovine coronary arteries.
    Gimeno MF; Sterin-Borda L; Borda ES; Lazzari MA; Gimeno AL
    Prostaglandins; 1980 Jun; 19(6):907-16. PubMed ID: 6992238
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of prostacyclin and of the stable prostacyclin analogue ZK 36374 on forearm blood flow and blood platelet behaviour in man.
    Cowley AJ; Heptinstall S; Hampton JR
    Thromb Haemost; 1985 Feb; 53(1):90-4. PubMed ID: 2581332
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological evaluation of 5-(Z,E)-13,14-didehydro-20-methyl-carboprostacyclin (FCE 22509).
    Ceserani R; Grossoni M; Ukmar G; Colombo M; Mongelli N
    Prostaglandins Leukot Med; 1986 Mar; 21(3):231-45. PubMed ID: 3517883
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interaction of prostaglandin D2 with prostacyclin, carbacyclin and the hydantoin prostaglandin, BW245C, in guinea-pig platelets.
    Hamid S; Whittle BJ
    Br J Pharmacol; 1985 May; 85(1):285-90. PubMed ID: 2992652
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Possible beta-adrenoceptor modulating effect of ZK 36 374 a stable analogue of carbacyclin.
    Ercan ZS; Türker RK
    Prostaglandins Leukot Med; 1984 Jul; 15(1):45-52. PubMed ID: 6206517
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mode of action of coronary arterial relaxation by prostacyclin.
    Holzmann S; Kukovetz WR; Schmidt K
    J Cyclic Nucleotide Res; 1980; 6(6):451-60. PubMed ID: 6163806
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of prostaglandins E2, I2 and F2 alpha on the tone of isolated coronary arteries from alloxan-diabetic dogs.
    Palik I; Koltai MZ; Hadházy P; Malomvölgyi B; Wagner M; Pogátsa G
    Prostaglandins Leukot Med; 1982 Jun; 8(6):607-14. PubMed ID: 7051047
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of the inhibitory effects of prostacyclin and carbacyclin on platelet adhesion to collagen.
    Karniguian A; Simmons P; Legrand YJ; Moncada S; Caen JP
    Prostaglandins; 1982 Dec; 24(6):827-36. PubMed ID: 6300971
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Platelet preservation during cardiopulmonary bypass (CPB) with prostaglandin (PGE1) and prostacyclin (PGI2).
    van den Dungen JJ; Velders AJ; Karliczek GF; Homan van der Heide JN; Wildevuur CR
    Trans Am Soc Artif Intern Organs; 1980; 26():481-6. PubMed ID: 7018057
    [No Abstract]   [Full Text] [Related]  

  • 35. Potentiation of antiaggregating effect of prostaglandins by alpha-tocopherol and quercetin.
    Mardla V; Kobzar G; Samel N
    Platelets; 2004 Aug; 15(5):319-24. PubMed ID: 15370103
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of platelet aggregation and antagonism of vasopressin-induced ECG changes in primates by a carboprostacyclin analogue, ZK 36374.
    Adaikan PG; Karim SM; Lau LC; Tai MY; Kottegoda SR
    Thromb Res; 1984 Feb; 33(3):333-40. PubMed ID: 6200948
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential inhibition of the platelet activation sequence: shape change, micro- and macro-aggregation, by a stable prostacyclin analogue (Iloprost).
    Pedvis LG; Wong T; Frojmovic MM
    Thromb Haemost; 1988 Apr; 59(2):323-8. PubMed ID: 2455359
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prostacyclin (PGI2) decreases the cyclic AMP level in coronary arteries.
    Schrör K; Rösen P
    Naunyn Schmiedebergs Arch Pharmacol; 1979 Jan; 306(1):101-3. PubMed ID: 218118
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Desensitization of PGE2 and PGI2 induced contractions in different smooth muscles of guinea-pig unmasking relaxing properties of prostanoids.
    Vermue NA; Den Hertog A; Zaagsma J
    Eur J Pharmacol; 1987 Dec; 144(3):399-403. PubMed ID: 2450036
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of prostaglandins and thromboxane analogues on bullock and dog iris sphincter preparations.
    Dong YJ; Jones RL
    Br J Pharmacol; 1982 May; 76(1):149-55. PubMed ID: 6177369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.